Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Microperimetry and High-Definition-OCT in Ranibizumab Treatment for Diabetic Macular Edema (MORE-Study)

NCT00885794 is registered in ClinicalTrials.gov with The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery as lead sponsor.

NCT NCT00885794
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00885794 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Microperimetry and High-Definition-OCT in Ranibizumab Treatment for Diabetic Macular Edema (MORE-Study)
Lead sponsor
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
Phase
Phase 2/3
Overall status
Unknown status
Start date
May 31, 2008
Completion date
May 31, 2012
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema